BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Bioinformatics Software | QIAGEN Digital Insights - ECPv6.15.17.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Bioinformatics Software | QIAGEN Digital Insights
X-ORIGINAL-URL:https://staging.digitalinsights.supremeclients.com
X-WR-CALDESC:Events for Bioinformatics Software | QIAGEN Digital Insights
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20220101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20220313T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20221106T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20230312T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20231105T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20240310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20241103T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20230610
DTEND;VALUE=DATE:20230614
DTSTAMP:20260404T084335
CREATED:20230525T162924Z
LAST-MODIFIED:20241024T182903Z
UID:10000646-1686355200-1686700799@staging.digitalinsights.supremeclients.com
SUMMARY:ESHG 2023
DESCRIPTION:Learn about our Sample to Insight solutions for inherited disorders\n\n\n\n\n\nThis year at the European Society for Human Genetics (ESHG) 2023 Annual Meeting\, QIAGEN will be at booth #472 premiering our new barrier-breaking Sample to Insight workflow for inherited disease NGS testing—a fast\, cheap\, ultra-precise panel to report pipeline. \nLearn more about our products and solutions and receive complimentary demos of our bioinformatic software and databases. Our experts will be available to chat with you and answer any questions you may have. We look forward to seeing you at ESHG 2023.
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/eshg-2023/
LOCATION:Glasgow\, Glasgow\, Scotland\, United Kingdom
CATEGORIES:Clinical,Event
ATTACH;FMTTYPE=image/jpeg:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/05/S_1305_1_QDI_QCI_Glasgow_GI519375418.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20230608T130000
DTEND;TZID=UTC:20230608T143000
DTSTAMP:20260404T084335
CREATED:20230418T131657Z
LAST-MODIFIED:20241024T182859Z
UID:10000637-1686229200-1686234600@staging.digitalinsights.supremeclients.com
SUMMARY:Antimicrobial resistance (AMR) and multi-locus sequence typing (MLST) using QIAGEN CLC Genomics Workbench
DESCRIPTION:You asked for it by popular demand\, and we’re here to deliver. In this training\, we’ll cover how antimicrobial resistance (AMR) is used for isolation or can be easily integrated with other functionalities such as multi-locus sequence typing (MLST).\nIn this training\, we’ll cover:\n• Introduction to AMR\, MLST and relevant databases\n• QIAGEN Microbial Insight - Antimicrobial Resistance database (QMI-AR)\n• Importing data and downloading needed databases\n• Finding resistance with nucleotide DB\, PointFinder and ShortBRED\n• Integrating AMR with MLST\n• Exporting high-resolution graphics and result tables
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/antimicrobial-resistance-amr-and-multi-locus-sequence-typing-mlst-using-qiagen-clc-genomics-workbench/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Discovery,Training
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20230608T110000
DTEND;TZID=UTC:20230608T120000
DTSTAMP:20260404T084335
CREATED:20230525T145821Z
LAST-MODIFIED:20241024T182901Z
UID:10000645-1686222000-1686225600@staging.digitalinsights.supremeclients.com
SUMMARY:Sample to Insight at LightSpeed: A barrier-breaking workflow for inherited disease NGS testing
DESCRIPTION:Get a first-hand look at QIAGEN’s new Sample to Insight Hereditary solution. By attending this webinar\, you will: \n\nLearn more about each workflow component.\nHear from experts in the field as they discuss how this technology advances the diagnosis and management of inherited diseases.\nExamine real-world case studies demonstrating the clinical utility and cost-effectiveness of the solution.\n\nIf your lab needs a fast\, cost-effective\, ultra-precise workflow for germline NGS testing\, you do not want to miss this webinar.
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/sample-to-insight-at-lightspeed-a-barrier-breaking-workflow-for-inherited-disease-ngs-testing/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Clinical,Webinar
ATTACH;FMTTYPE=image/jpeg:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/05/16x9.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20230607T110000
DTEND;TZID=UTC:20230607T123000
DTSTAMP:20260404T084335
CREATED:20230511T112735Z
LAST-MODIFIED:20241024T182900Z
UID:10000640-1686135600-1686141000@staging.digitalinsights.supremeclients.com
SUMMARY:Unlocking the power of API-based 'omics queries
DESCRIPTION:If you're a data scientist or bioinformatician working in biopharma\, here's your chance to explore an advanced and comprehensive way to access and analyze high-quality 'omics data. The QIAGEN OmicSoft API provides a powerful and flexible platform for easy data discovery\, retrieval\, filtering\, analysis and visualization. In this webinar\, you'll learn how to leverage the OmicSoft API to access vast amounts of multi-omics data and perform custom analyses. We will also highlight the capabilities of the OmicSoft API to query across data sources to obtain a complete picture of the available 'omics data for any given disease. \nJoin us to learn how OmicSoft API can revolutionize your data analysis workflows and help you make more informed decisions for your drug and target discovery projects. \nIn this webinar\, we'll discuss how to: \n\nAvoid the pitfalls of poorly labeled data\nUse the OmicSoft API to accelerate queries and promote consistency\nPerform multi' omics data analysis to reveal patterns and prioritize hypotheses\nLeverage curated metadata\, including sample clinical data\, to structure queries\nDrive efficiency in your drug discovery and bioinformatics programs\n\nDon't miss this chance to learn how to unlock the power of API-based 'omics queries.
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/unlocking-the-power-of-api-based-omics-queries-jun-7/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Discovery,Webinar
ATTACH;FMTTYPE=image/jpeg:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/05/faefb219-97c3-467a-b5aa-4c5f12517be6.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20230606
DTEND;VALUE=DATE:20230609
DTSTAMP:20260404T084335
CREATED:20230504T134649Z
LAST-MODIFIED:20241024T182859Z
UID:10000639-1686009600-1686268799@staging.digitalinsights.supremeclients.com
SUMMARY:Roman Testing Conference
DESCRIPTION:In 2023\, we want to hear stories of improved communication and bridging gaps. Of technology used to harness the power of agility. Of process improvements\, impediments removal and common goals. About changing attitudes\, ways of working and minds. We want to hear stories of failure or win\, standing up against change or championing it. What you changed. What you learned from it. \nWe are looking to build a program offering a wide variety of inspiring talks and hands-on workshops. The conference will span over 3 days with the first two days consisting of one- and two-day workshops and training. On the third day we will have a classic multi-track setup with a variety of keynotes and talks. We will also be trying out a few exciting concepts that we will share more information about along the way.
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/roman-testing-conference-jun-6-8/
LOCATION:Romania\, Cluj-Napoca\, Romania
CATEGORIES:Clinical,Event
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20230525T130000
DTEND;TZID=UTC:20230525T143000
DTSTAMP:20260404T084335
CREATED:20230503T054433Z
LAST-MODIFIED:20241024T182859Z
UID:10000638-1685019600-1685025000@staging.digitalinsights.supremeclients.com
SUMMARY:Acceda rápidamente a amplios conocimientos para interpretar variantes somáticas con la HSMD
DESCRIPTION:Dentro de las aplicaciones oncológicas\, la capacidad de identificar alteraciones genéticas potencialmente accionables y explorar las vulnerabilidades moleculares del cáncer es cada vez más difícil. \n\nUna nueva base de datos desarrollada por QIAGEN\, la HSMD\, contiene más de 2 décadas de contenido curado por expertos y datos de la QIAGEN Knowledge Base con más de 300.000 casos de oncología del mundo real para proporcionar una comprensión profunda y precisa de la accionabilidad de pequeñas variantes\, como SNVs\, indels y frameshifts\, que han sido "clínicamente observadas" o consideradas por la literatura científica. \n\nEl 25 de mayo\, únase a nuestros expertos en un tour virtual a la nueva base de datos y una presentación de sus características\, capacidades y aplicaciones.
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/acceda-rapidamente-a-amplios-conocimientos-para-interpretar-variantes-somaticas-con-la-hsmd-may-25/
LOCATION:Virtual - Argentina\, Argentina
CATEGORIES:Clinical,Webinar
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20230523T130000
DTEND;TZID=UTC:20230523T143000
DTSTAMP:20260404T084335
CREATED:20230418T125027Z
LAST-MODIFIED:20241024T182856Z
UID:10000635-1684846800-1684852200@staging.digitalinsights.supremeclients.com
SUMMARY:IPA deeper dive: miRNA investigation using QIAGEN Ingenuity Pathway Analysis (IPA)
DESCRIPTION:In this 90-minute training session\, you will learn how to identify target mRNAs for your miRNAs of interest and associate them with pathways\, diseases\, biological functions\, tissues and cell types. \nWe’ll cover topics such as:\n- How to analyze miRNA-seq datasets alone\, or both miRNA and corresponding mRNA datasets together\n- How to use QIAGEN IPA without a dataset\, using miRNA IDs\n- Introduction to databases and curated content specific to miRNA\n- How to effectively apply various filters and functionalities to identify biomarkers\, key targets and novel biological mechanisms
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/ipa-deeper-dive-mirna-investigation-using-qiagen-ingenuity-pathway-analysis-ipa-2/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Discovery,Training
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20230518T100000
DTEND;TZID=UTC:20230518T120000
DTSTAMP:20260404T084335
CREATED:20230329T122532Z
LAST-MODIFIED:20241024T182851Z
UID:10000626-1684404000-1684411200@staging.digitalinsights.supremeclients.com
SUMMARY:How to improve your existing pipeline for somatic mutation analysis\, interpretation and reporting: Part 2
DESCRIPTION:We are excited to bring thought leaders\, NGS experts\, lab directors\, variant scientists\, clinicians\, and oncologists under one virtual roof at our second annual Clinical Oncology Summit hosted on April 27 and May 18\, 2023. \nThe two-part\, content-rich event will feature invited lectures from lab directors and clinical geneticists\, thought-provoking discussions on the future of comprehensive genomic profiling\, and educational presentations on the latest databases\, software\, and services for somatic secondary and tertiary analysis. Designed to help clinical diagnostic labs understand how they can optimize their current pipelines for somatic NGS analysis\, interpretation and reporting\, the Clinical Oncology Summit is a must-attend event for labs who need to reduce turnaround time\, improve operational costs\, and scale for higher throughput. \nMeet the speakers and view the full agenda here.
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/how-to-improve-your-existing-pipeline-for-somatic-mutation-analysis-interpretation-and-reporting-part-2/
CATEGORIES:Clinical,Event
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20230516T130000
DTEND;TZID=UTC:20230516T143000
DTSTAMP:20260404T084335
CREATED:20230418T124321Z
LAST-MODIFIED:20241024T182856Z
UID:10000634-1684242000-1684247400@staging.digitalinsights.supremeclients.com
SUMMARY:Pathway and network analysis on different types of lists with QIAGEN IPA
DESCRIPTION:You may not have a typical transcriptomics dataset (i.e.\, a list of genes with differential expression)\, yet\, you’d like to analyze a list of IDs. In this training\, we will explore how to perform pathway and network analysis for lists of IDs in QIAGEN IPA.\nExamples of lists that we’ll explore include:\n• A gene/protein/metabolite list coming from a paper\, generated in a lab or from a collaborator without differential expression\n• A list of RS IDs for variants with or without numerical values such as p-values\n• A list of proteins with Z-score (or other numerical value) calculated outside of IPA\n• Other lists where you have mainly IDs and but no differential expression data \nIn this IPA training\, you’ll learn how to:\n• Upload and perform a pathway analysis (also known as core analysis) on a list of genes\, proteins\, metabolites or other types of IDs\n• Open and investigate pathways and networks for understanding biological mechanisms\n• Compare between analyses to identify similarities and differences for applications such as biomarker discovery\n• Generate a custom network and contextualize it using public data
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/pathway-and-network-analysis-on-different-types-of-lists-with-qiagen-ipa/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Discovery,Webinar
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20230516T100000
DTEND;TZID=UTC:20230516T113000
DTSTAMP:20260404T084335
CREATED:20230418T123846Z
LAST-MODIFIED:20241024T182856Z
UID:10000633-1684231200-1684236600@staging.digitalinsights.supremeclients.com
SUMMARY:How to improve your existing pipeline for somatic mutation analysis\, interpretation and reporting: Part 2
DESCRIPTION:We are excited to bring thought leaders\, NGS experts\, lab directors\, variant scientists\, clinicians\, and oncologists under one virtual roof at our second annual Clinical Oncology Summit hosted on April 27 and May 18\, 2023. \nThe two-part\, content-rich event will feature invited lectures from lab directors and clinical geneticists\, thought-provoking discussions on the future of comprehensive genomic profiling\, and educational presentations on the latest databases\, software\, and services for somatic secondary and tertiary analysis. Designed to help clinical diagnostic labs understand how they can optimize their current pipelines for somatic NGS analysis\, interpretation and reporting\, the Clinical Oncology Summit is a must-attend event for labs who need to reduce turnaround time\, improve operational costs\, and scale for higher throughput. \nMeet the speakers and view the full agenda here.
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/how-to-improve-your-existing-pipeline-for-somatic-mutation-analysis-interpretation-and-reporting-part-2-2/
LOCATION:Virtual - EMEA - CET
CATEGORIES:Clinical,Webinar
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20230511T130000
DTEND;TZID=UTC:20230511T143000
DTSTAMP:20260404T084335
CREATED:20230418T123154Z
LAST-MODIFIED:20241024T182855Z
UID:10000632-1683810000-1683815400@staging.digitalinsights.supremeclients.com
SUMMARY:Checkpoint inhibitors in the context of biomarkers\, drug targets and pathways
DESCRIPTION:In this training\, we will focus on how you can use QIAGEN Omicsoft Studio and QIAGEN Ingenuity Pathway Analysis (IPA) to discover new biomarkers\, validate (or study) drug targets and identify novel mechanisms of action with your own and/or public checkpoint inhibitor datasets from resources like GEO\, SRA\, TCGA and more. \nIn this training\, you’ll learn how to: \n· Investigate the expression of a gene/biomarker/drug target across different treatments and diseases \n· Derive a biomarker/gene signature from a specific condition (for example\, non-responders of a drug\, or a particular disease/disease subtype and others) \n· Correlate expression of multiple genes and biomarkers \n· Compare different experimental groups (e.g.\, your own data and/or public data) at both the levels of gene expression and pathways/regulatory networks activity
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/checkpoint-inhibitors-in-the-context-of-biomarkers-drug-targets-and-pathways/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Discovery,Webinar
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20230509T130000
DTEND;TZID=UTC:20230509T143000
DTSTAMP:20260404T084335
CREATED:20230411T170801Z
LAST-MODIFIED:20241024T182854Z
UID:10000629-1683637200-1683642600@staging.digitalinsights.supremeclients.com
SUMMARY:Whole genome sequencing (WGS)\, rapid WGS and ultra-rapid WGS for hereditary disorders – where speed matters
DESCRIPTION:QIAGEN CLC LightSpeed Module delivers an ultra-fast\, end-to-end hereditary NGS FASTQ to VCF pipeline. LightSpeed takes raw FASTQ files generated by paired-end 150 bp sequencing protocols and performs quality trimming\, adapter trimming\, read mapping\, deduplication\, local realignment\, QC and germline variant calling. \nMore details: https://qiagen.showpad.com/share/Tue4ZxKsjAFetyoswbTfE \nCloud module: QIAGEN CLC Genomics Cloud computing software allows you to launch analyses from CLC Workbenches or CLC Servers for execution on AWS.\nhttps://qiagen.showpad.com/share/ct2e3M9LfLazzuMMchqhG\n• Overview of Genomics workbench and Platform\n• Server / Cloud module overview\n• Breaking the speed of light\n• LightSpeed is arguably the fastest and cheapest-to-run hereditary FASTQ-to-VCF WGS pipeline available\n• Benchmarks / comparisons\n• Demo of lightspeed and cloud module for Fastq to vcf\n• Install plugin\n• Download reference(s)\n• Execute workflow and review results
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/whole-genome-sequencing-wgs-rapid-wgs-and-ultra-rapid-wgs-for-hereditary-disorders-where-speed-matters-2/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Discovery,Webinar
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20230504T130000
DTEND;TZID=UTC:20230504T143000
DTSTAMP:20260404T084335
CREATED:20230418T122646Z
LAST-MODIFIED:20241024T182855Z
UID:10000631-1683205200-1683210600@staging.digitalinsights.supremeclients.com
SUMMARY:Single-cell RNA-seq data analysis and interpretation
DESCRIPTION:Explore how to analyze and interpret your own single-cell RNA-seq (scRNA-seq) data using QIAGEN CLC Genomics Workbench and QIAGEN Ingenuity Pathway Analysis (IPA). \nIn this 90-minute training\, you’ll learn how to:\n• Start with FASTQ\, cell matrix file and/or differential expression file for scRNA-seq data\n• Either automate or customize your analysis pipeline/workflow\, depending on your needs\n• Easily generate visualizations such as t-SNE\, UMAP\, heatmap\, differential expression table\, dot plots and more\n• Upload differential expression data to QIAGEN IPA (either from QIAGEN CLC or from another source)\n• Perform pathway analysis on scRNA-seq data and compare different clusters to discover novel biological mechanisms\, cell type-specific biomarkers and key regulators/targets\n• Export results in the form of high-quality images or tabular format \nSlides from a previous similar training: https://qiagen.showpad.com/share/WAXz1vrHBsvArdeceWpcX
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/single-cell-rna-seq-data-analysis-and-interpretation/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Discovery,Training
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20230504T110000
DTEND;TZID=UTC:20230504T120000
DTSTAMP:20260404T084335
CREATED:20230329T123527Z
LAST-MODIFIED:20241024T182853Z
UID:10000628-1683198000-1683201600@staging.digitalinsights.supremeclients.com
SUMMARY:Como anotar variantes somáticas e avaliar a prevalência delas com um único banco de dados
DESCRIPTION:Dentro das aplicações oncológicas\, a habilidade de identificar alterações genéticas potencialmente acionáveis e explorar as vulnerabilidades moleculares do câncer está se tornando cada vez mais difícil. \nUm novo banco de dados desenvolvido pela QIAGEN\, o HSMD\, contém mais de 2 décadas de conteúdo com curadoria especializada e dados da QIAGEN Knowledge Base com mais de 300.000 casos oncológicos de mundo real para fornecer um entendimento profundo e preciso da acionabilidade de variantes pequenas\, tais como SNVs\, indels e frameshifts\, que têm sido “observadas clinicamente” ou consideradas pela literatura científica. \nNo dia 4 de maio\, junte-se a nossos especialistas para um tour virtual do novo banco de dados e apresentação dos seus recursos\, capacidades e aplicações.
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/como-anotar-variantes-somaticas-e-avaliar-a-prevalencia-delas-com-um-unico-banco-de-dados/
LOCATION:Virtual - Portugal\, Portugal
CATEGORIES:Clinical,Webinar
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20230427T130000
DTEND;TZID=UTC:20230427T143000
DTSTAMP:20260404T084335
CREATED:20230316T151730Z
LAST-MODIFIED:20241024T182849Z
UID:10000621-1682600400-1682605800@staging.digitalinsights.supremeclients.com
SUMMARY:QIAGEN Ingenuity Pathway Analysis (IPA) for grant writing and publications with new features
DESCRIPTION:QIAGEN Ingenuity Pathway Analysis (IPA) represents a robust resource to aid in the process of writing grants publications. Driven by a wealth of manually-curated molecular interactions and associations in the QIAGEN Knowledge Base together with pre-analyzed public ‘omics data for hundreds of thousands of samples from QIAGEN OmicSoft Lands\, IPA provides biological insights regardless of whether you have your own data or not. In the absence of your own data\, IPA provides a resource to query existing molecular knowledge from the literature or public ‘omics data\, build networks in silico\, and review results from pre-analyzed public studies. With data\, you can dig deeply into the biological meaning of your results through the identification of key pathways\, regulatory molecules and functional changes as well as understand how your study relates to other published studies. \nJoin us for a 90-min training session where you will learn: \n• Ways to query IPA’s vast collection of curated literature and ‘omics data\n• How molecules relate to phenotypes and functions\n• Build your own networks and predict activity changes\n• Ways to explore a library of over 100\,000 precomputed IPA analyses pulled from public ‘omics data\n• How to format your dataset and set up an analysis\n• How to deeply interrogate key Canonical Pathway\n• How to predict regulators which are causing your expression changes\n• How to contextualize the result of your analysis by comparing your results to internal and public data\n• Ways to generate the necessary tables and figures for your manuscript
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/qiagen-ingenuity-pathway-analysis-ipa-for-grant-writing-and-publications-with-new-features/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Discovery,Webinar
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20230427T100000
DTEND;TZID=UTC:20230427T120000
DTSTAMP:20260404T084335
CREATED:20230329T121854Z
LAST-MODIFIED:20241024T182850Z
UID:10000625-1682589600-1682596800@staging.digitalinsights.supremeclients.com
SUMMARY:How to improve your existing pipeline for somatic mutation analysis\, interpretation and reporting: Part 1
DESCRIPTION:We are excited to bring thought leaders\, NGS experts\, lab directors\, variant scientists\, clinicians\, and oncologists under one virtual roof at our second annual Clinical Oncology Summit hosted on April 27 and May 18\, 2023. \nThe two-part\, content-rich event will feature invited lectures from lab directors and clinical geneticists\, thought-provoking discussions on the future of comprehensive genomic profiling\, and educational presentations on the latest databases\, software\, and services for somatic secondary and tertiary analysis. Designed to help clinical diagnostic labs understand how they can optimize their current pipelines for somatic NGS analysis\, interpretation and reporting\, the Clinical Oncology Summit is a must-attend event for labs who need to reduce turnaround time\, improve operational costs\, and scale for higher throughput. \nMeet the speakers and view the full agenda here.
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/how-to-improve-your-existing-pipeline-for-somatic-mutation-analysis-interpretation-and-reporting-part-1/
CATEGORIES:Clinical,Event
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20230425T130000
DTEND;TZID=UTC:20230425T143000
DTSTAMP:20260404T084335
CREATED:20230315T134937Z
LAST-MODIFIED:20241024T182848Z
UID:10000620-1682427600-1682433000@staging.digitalinsights.supremeclients.com
SUMMARY:Proteomics and phosphoproteomics data interpretation using QIAGEN Ingenuity Pathway Analysis
DESCRIPTION:In this live QIAGEN Ingenuity Pathway Analysis (IPA) training\, we’ll focus on interpreting proteomics and phosphoproteomics datasets. \nIn this tutorial\, we’ll guide you through steps and workflows to address your questions related to interpreting proteomics and phosphoproteomics datasets using QIAGEN IPA\, such as:\n• How should I format the data before uploading to IPA?\n• How do I set up the analysis?\n• Which upstream kinases are implicated in the observed phosphoproteomics changes?\n• What are the targets of a particular upstream kinase and how do their levels of phosphorylation change over the time course?\n• What are the targets on a particular Canonical Pathway and how do their levels of phosphorylation change over time?\n• Which biological predictions trend in a time-dependent manner during the time course?\n• How do the biological predictions from phosphoproteomics compare with a related transcriptomics dataset? \nAdditional QIAGEN Digital Insights (QDI) scientists will be on the call to answer questions and help with other inquiries\, such as how to install the software\, etc. \nFor those with a QIAGEN IPA license\n• To install IPA before or after the training\, please use the below installer.\nhttps://qiagen.showpad.com/share/CBv30blCPKFDUYHRWtAvI\n• If you haven’t done core analysis in IPA before\, we recommend you review below video/slides before the training (however\, this is not required).\no IPA beginner training recording: https://qiagen.showpad.com/share/t2cGMdF3NjVucBA0b9tIT \no IPA step-by-step guide w/ data format (slide 9) and upload (slide 28) instructions: https://qiagen.showpad.com/share/VjizSLJVBw1qfV
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/proteomics-and-phosphoproteomics-data-interpretation-using-qiagen-ingenuity-pathway-analysis/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Discovery,Webinar
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20230419T110000
DTEND;TZID=UTC:20230419T120000
DTSTAMP:20260404T084335
CREATED:20230317T121304Z
LAST-MODIFIED:20241024T182849Z
UID:10000622-1681902000-1681905600@staging.digitalinsights.supremeclients.com
SUMMARY:Shed light on inherited mutations and solve hereditary investigations with QCI Interpret
DESCRIPTION:In this webinar\, we will demonstrate how QCI Interpret can improve your diagnostic yield for hereditary disorders. QCI Interpret is a clinical decision support platform that leverages augmented molecular intelligence to streamline the interpretation workflow. It uses the most extensive\, globally trusted and manually curated molecular knowledge and bibliography evidence to provide you with the best possible opportunity to solve every case. By demonstrating the different features and series of use-cases\, we will show you how QCI Interpret guarantees a comprehensive and thorough investigation of every case for all types of genetic variation\, including copy number variants (CNVs). This will allow you to provide precise answers to patients and their families\, while also reducing test turnaround time from hours to minutes. \nLearning objectives: \n\nLearn about QCI Interpret’s analysis and interpretation workflow for hereditary diseases using targeted and extended gene panels\, including WES/WGS\nLearn about QCI Interpret and QIAGEN’s expert curation process based on the latest ACMG carrier screening guidelines\nView demonstrations of unique features in QCI Interpret\, including how to input symptoms relevant to a case and receive relationships to candidate diseases and mutated genes using the Phenotype Network Analysis feature and triage mode of variant assessment.\nLearn how QCI Interpret supports CNV interpretation and reporting with bibliographic coverage of over 60\,000 CNV case reports"
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/shed-light-on-inherited-mutations-and-solve-hereditary-investigations-with-qci-interpret/
CATEGORIES:Clinical,Webinar
ATTACH;FMTTYPE=image/jpeg:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/05/WEBINAR_QCI_RockReleaseWebinar_0323_16x9.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20230418T130000
DTEND;TZID=UTC:20230418T143000
DTSTAMP:20260404T084335
CREATED:20230315T134308Z
LAST-MODIFIED:20241024T182848Z
UID:10000619-1681822800-1681828200@staging.digitalinsights.supremeclients.com
SUMMARY:Public single-cell RNA-seq data investigation using QIAGEN OmicSoft and Ingenuity Pathway Analysis
DESCRIPTION:Single-cell RNA-sequencing (scRNA-seq) is widely used to investigate tissue heterogeneity\, identify novel cell types\, study pathogenic mechanisms\, develop targeted therapy (including immunotherapy) and more. Accordingly\, a tremendous amount of scRNA-seq data has been deposited to public domains like GEO. \nIn this training\, you will learn how to \n· Locate public single-cell studies of interest using QIAGEN Omicsoft Single Cell Lands \n· Study different cell types by dimension reduction plots (for example\, t-SNE\, UMAP) \n· Investigate expression of genes of interest across different cell types (Violin plots\, overlay expression on cluster) \n· Identify key pathways and regulators from scRNA-seq data using QIAGEN Ingenuity Pathway Analysis (IPA)
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/public-single-cell-rna-seq-data-investigation-using-qiagen-omicsoft-and-ingenuity-pathway-analysis/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Discovery,Training
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20230413T130000
DTEND;TZID=UTC:20230413T143000
DTSTAMP:20260404T084335
CREATED:20230315T134055Z
LAST-MODIFIED:20241024T182848Z
UID:10000618-1681390800-1681396200@staging.digitalinsights.supremeclients.com
SUMMARY:Make discoveries from public data (GEO\, SRA and more) using QIAGEN Ingenuity Pathway Analysis
DESCRIPTION:You asked for it\, and we’re here to deliver. We are hosting a comprehensive training on effectively using sample-level public data and metadata from sources like GEO\, SRA\, TCGA\, GTEx\, Blueprint\, CCLE and others through QIAGEN Ingenuity Pathway Analysis (IPA) and the IPA Analysis Match Explorer feature. We’ll walk you through use cases involving biomarker discovery\, drug target investigation\, studying survival in custom patient cohorts\, multi-gene correlation and more. \nWe’ll cover topics like:\n• How is a gene of interest expressed across different conditions?(‘conditions’ refers to diseases\, disease subtypes\, treatments\, cell types\, cell lines and more)\n• Is there a correlation in expression for two genes or biomarkers of user interest for a given condition?\n• Can we compare more than two genes in a heatmap?\n• For a given condition of interest\, can we derive a list of genes (for example\, genes specific to a disease\, treatment or cell type)?\n• Can we generate custom cohorts of patients (for example\, TP53 wt vs. mutant or PDCD1 high vs. low expression) and then create survival curves representing those cohorts? Can we generate a p-value to see if there is a significant difference?\n• Can we detect the expression of a gene in different cell types from single-cell data?
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/make-discoveries-from-public-data-geo-sra-and-more-using-qiagen-ingenuity-pathway-analysis/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Discovery,Webinar
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20230413T110000
DTEND;TZID=UTC:20230413T120000
DTSTAMP:20260404T084335
CREATED:20230329T120940Z
LAST-MODIFIED:20241024T182850Z
UID:10000624-1681383600-1681387200@staging.digitalinsights.supremeclients.com
SUMMARY:Take your genome research to the next level with QCI Interpret Translational
DESCRIPTION:Learn how QCI Interpret Translational can get your research to the next level by providing you all the necessary analysis tools with the world’s most comprehensive and up-to-date curated scientific evidence. Get valuable and reliable insights for your research project and speed up your discoveries by using a streamlined NGS analysis workflow in a user-friendly interface without needing bioinformatics expertise. \nIn this webinar\, attendees will have the opportunity to: \n\nExplore capabilities which can enable them to accelerate discoveries from hereditary or tumor cohort analyses\nDiscover interactive tools with current and comprehensive associations between gene variants and diseases\nLearn how these resources are supported by unique curated content among other integrated scientific evidence
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/take-your-genome-research-to-the-next-level-with-qci-interpret-translational/
CATEGORIES:Clinical,Webinar
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20230411T130000
DTEND;TZID=UTC:20230411T143000
DTSTAMP:20260404T084335
CREATED:20230315T133702Z
LAST-MODIFIED:20241024T182846Z
UID:10000617-1681218000-1681223400@staging.digitalinsights.supremeclients.com
SUMMARY:Pathogen detection in wastewater samples using QIAGEN CLC Genomics Workbench
DESCRIPTION:In this 90-minute training\, you will learn how to easily analyze wastewater samples to detect pathogens (SARS-COV2\, etc.) using QIAGEN CLC Genomics Workbench software. \nYou will learn how to:\n• Importing reads\n• Open and modify prebuilt workflow (analysis pipeline)\n• Install and execute workflow\n• Review QC reports\n• Perform genome visualization\n• Export the consensus sequence in FASTA format to upload to Pangolin\n• Create a SNP tree of the consensus sequence and overlay Pangolin information\n• Export graphical and tabular results
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/pathogen-detection-in-wastewater-samples-using-qiagen-clc-genomics-workbench/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Discovery,Webinar
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20230405T110000
DTEND;TZID=UTC:20230405T120000
DTSTAMP:20260404T084335
CREATED:20230329T120420Z
LAST-MODIFIED:20241024T182849Z
UID:10000623-1680692400-1680696000@staging.digitalinsights.supremeclients.com
SUMMARY:Can you trust AI for germline variant curation? A Stanford University case study
DESCRIPTION:In this webinar\, we examine a new study by Stanford University that analyzes the accuracy\, consistency\, and comprehensiveness of automated and manual germline variant curation. The study compares the quality of data from Stanford’s Automatic VAriant evidence DAtabase (AVADA) to the Human Gene Mutation Database (HGMD)\, an expert-curated resource for human inherited disease mutations. \nBy attending this webinar\, you will: \n\nAnalyze a series of use-cases comparing the performance of AI-driven variant curation to manual approaches\nReceive a virtual demonstration of how HGMD presents mutation data\, including how the database provides genomic coordinates\, Human Genome Variation Society (HGVS) nomenclatures for variants\, citations from key publications\, and where a variant is described in a paper or supplemental text\nLearn how HGMD simplifies literature review and supports CNV interpretation\nReceive a complimentary 5-day trial of HGMD Professional
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/can-you-trust-ai-for-germline-variant-curation-a-stanford-university-case-study/
CATEGORIES:Clinical,Webinar
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230404T130000
DTEND;TZID=America/New_York:20230404T143000
DTSTAMP:20260404T084335
CREATED:20230307T180301Z
LAST-MODIFIED:20241024T182844Z
UID:10000613-1680613200-1680618600@staging.digitalinsights.supremeclients.com
SUMMARY:New user training: Large dataset analysis and knowledge base queries using QIAGEN Ingenuity Pathway Analysis (IPA)
DESCRIPTION:Join us for a 90-minute training session for new users of QIAGEN IPA. \nIn this training\, you’ll learn how to:\n• Upload your dataset (RNA-seq\, scRNA-seq\, proteomics\, metabolomics and more) and perform interactive core/pathway analysis in IPA\n• Understand the different result types produced (pathways\, key regulators\, impact on biological functions/diseases and more)\n• Compare different experimental conditions (treatments\, time points\, single-cell clusters\, disease types and more) and identify similarities and contrasts\n• Generate a network even without a dataset or experimental design for hypothesis generation \nFor those with IPA license\,\nTo install IPA before or after this training\, please use below installer.\nhttps://qiagen.showpad.com/share/CBv30blCPKFDUYHRWtAvI
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/new-user-training-large-dataset-analysis-and-knowledge-base-queries-using-qiagen-ingenuity-pathway-analysis-ipa-2/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Discovery,Training
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20230330T100000
DTEND;TZID=UTC:20230330T110000
DTSTAMP:20260404T084335
CREATED:20230329T123208Z
LAST-MODIFIED:20241024T182851Z
UID:10000627-1680170400-1680174000@staging.digitalinsights.supremeclients.com
SUMMARY:Accéder rapidement à une connaissance exhaustive pour l’interprétation des variants somatiques avec HSMD
DESCRIPTION:L’interprétation et la classification des variants somatiques demeurent un challenge alors que le nombre de gènes testés continue d’augmenter faisant apparaitre de nouvelles altérations. Ces nouveaux variants dont l’impact clinique est encore inconnu nécessitent une recherche d’information croisée à partir de nombreuses sources. Déterminer la classification d’un variant peut donc s’avérer longue et fastidieuse. La base de variants somatiques HSMD est une ressource en ligne qui vous permet rapidement et en toute confiance de classer vos nouveaux variants. En effet\, HSMD contient plus de 300 000 cas en oncologie clinique et plus de 1\,5 millions de mutations et leurs données associées\, manuellement capturées et intégrées dans la base de connaissance QIAGEN. Le profil mutationnel de gènes d’intérêt\, les gènes fréquemment mutés dans une pathologie donnée\, l’actionnabilité d’un gène ou encore les essais cliniques pour un cancer ou un traitement spécifique sont des requêtes que les utilisateurs d’HSMD peuvent effectuer simplement. Vous découvrirez lors de ce webinaire comment utiliser HSMD pour votre routine clinique ou dans un cadre de recherche translationnelle.
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/acceder-rapidement-a-une-connaissance-exhaustive-pour-linterpretation-des-variants-somatiques-avec-hsmd/
CATEGORIES:Clinical,Training
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230323T130000
DTEND;TZID=America/New_York:20230323T143000
DTSTAMP:20260404T084335
CREATED:20230307T163759Z
LAST-MODIFIED:20241024T182839Z
UID:10000607-1679576400-1679581800@staging.digitalinsights.supremeclients.com
SUMMARY:Multi-omics (metabolomics\, proteomics\, transcriptomics) analysis using QIAGEN Ingenuity Pathway Analysis
DESCRIPTION:This 90-minute training session is about how QIAGEN Ingenuity Pathway Analysis (IPA) allows visualization of molecular intricacy and variations at multiple levels such as transcriptome\, proteome\, and metabolome. Through a series of brief technical vignettes\, it is demonstrated how to: \n· Generate associations among molecular signatures obtained via integrating multi-omics data \n· Extract mechanisms from multi-omics data for precision medicine \n· Disease stratification based on multi-omics profiles \n· Map disease networks among targets and indications \n  \nClick here to register.
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/multi-omics-metabolomics-proteomics-transcriptomics-analysis-using-qiagen-ingenuity-pathway-analysis-3/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Discovery,Webinar
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230323T110000
DTEND;TZID=America/New_York:20230323T120000
DTSTAMP:20260404T084335
CREATED:20230309T161946Z
LAST-MODIFIED:20241024T182845Z
UID:10000614-1679569200-1679572800@staging.digitalinsights.supremeclients.com
SUMMARY:How to simplify somatic NGS analysis & reduce literature review time by 90% with HSMD
DESCRIPTION:Across clinical oncology applications\, from molecular testing to cancer research\, the ability to identify potentially actionable genomic and genetic alterations to exploit the molecular vulnerabilities of cancer is a burgeoning field. Due to the sporadic nature of somatic cancers and the expansion of next-generation sequencing\, the number of variants detected through tumor testing is growing exponentially\, presenting a challenge to clinical cancer genetics professionals working to confidently identify meaningful mutations that could influence decision-making at point-of-care.\n\nJoin Chelsea Alexander\, a certified genetic counselor\, and Aarthi Goverdhan\, our lead oncology application development scientist\, for a live webinar on Thursday\, March 23rd at 11 AM EST to discover a new database that can streamline your somatic NGS analysis and significantly reduce your literature review time—by up to 90%!\n\nIn this webinar\, we will introduce you to the Human Somatic Mutation Database (HSMD)—a new somatic database developed by QIAGEN that contains extensive genomic content relevant to solid tumors and hematological malignancies. Available as a web-based application\, this expert-curated resource contains data from over 419\,000 real-world clinical oncology cases combined with insights from the QIAGEN Knowledge Base\, providing clinically observed variant frequencies across diseases\, and diving deep into gene-level\, alteration-level and disease-level information. Users can easily search and explore mutational characteristics across genes\, synthesize key findings from drug labels and professional guidelines\, explore clinical trials\, and receive detailed annotations for each observed variant. In addition\, users can interrogate a bibliography of over 170\,000 PubMed articles and access detailed alteration-specific summaries written by PhD scientists.
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/how-to-simplify-somatic-ngs-analysis-reduce-literature-review-time-by-90-with-hsmd/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Clinical,Webinar
ATTACH;FMTTYPE=image/png:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/05/EmailHeader_LabrootsWebinarHSMD_0223_16x9_round.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20230322T120000
DTEND;TZID=UTC:20230322T130000
DTSTAMP:20260404T084335
CREATED:20230310T075449Z
LAST-MODIFIED:20241024T182845Z
UID:10000615-1679486400-1679490000@staging.digitalinsights.supremeclients.com
SUMMARY:Lowering NGS analysis cost at lightspeed
DESCRIPTION:Advances in next-generation sequencing (NGS) technologies over the years have significantly decreased the cost of whole genome (WGS) and whole exome (WES) applications\, such that they are considered the standard of care within multiple healthcare organizations. Arguably\, the most significant NGS challenges lie within data analysis and interpretation. Various parameters such as sensitivity\, specificity\, cost and speed are critical for secondary analysis\, while accurate\, comprehensive and up-to-date content is required for reliable interpretation. These aspects are crucial\, especially where rapid turnaround times are critical for improved health outcomes. There is no better example than the implementation of WES and WGS in the neonatal and pediatric intensive care units (NICU/PICU). \nJoin this webinar to learn about QIAGEN CLC LightSpeed\, a secondary analysis software that dramatically reduces the cost and time it takes to analyze WES and WGS data and generate actionable insights. \nKey learning objectives \n\nLearn how to process FASTQ files to obtain quality variant calls in minutes\nDiscover how LightSpeed can be used on existing laptops\, desktops\, servers\, HPC or in the cloud\nLearn how LightSpeed will reduce your cost without sacrificing quality\nExplore how LightSpeed enables the fastest WES and WGS workflow from FASTQ to report\n\nWho should attend? \nBioinformaticians\, Geneticists\, Lab managers\, NGS technicians\, researchers\, and biologists
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/lowering-ngs-analysis-cost-at-lightspeed/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Discovery,Webinar
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230316T130000
DTEND;TZID=America/New_York:20230316T143000
DTSTAMP:20260404T084335
CREATED:20230307T175844Z
LAST-MODIFIED:20241024T182844Z
UID:10000612-1678971600-1678977000@staging.digitalinsights.supremeclients.com
SUMMARY:IPA deeper dive: Generating novel discoveries in IPA - even when you don’t have data
DESCRIPTION:Take a deeper dive into the discovery capabilities of QIAGEN IPA. In this training\, you will learn how to:\n• Leverage the IPA knowledge base to generate hypotheses regarding novel biological mechanisms\, discover biomarkers and targets as well as design experiments.\n• Generate interactive networks using genes\, chemicals and diseases of interest\n• Search and interpret pathway analyses generated from public data (GEO\, SRA etc.)\n• Study gene or biomarker expression across different tissues\, diseases\, cell types and more from public sources\n• Correlate expression of genes across your biological condition of interest\n• Generate survival curves for cohorts generated based on expression or mutation status of a gene \nSpecific IPA analyses to be featured include:\n• Network construction (with and without data) • Activity Plot • Pattern Search • QIAGEN OmicSoft Land Explorer • Among others
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/ipa-deeper-dive-generating-novel-discoveries-in-ipa-even-when-you-dont-have-data/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Discovery,Training
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20230314T130000
DTEND;TZID=UTC:20230314T143000
DTSTAMP:20260404T084335
CREATED:20230307T172637Z
LAST-MODIFIED:20241024T182843Z
UID:10000609-1678798800-1678804200@staging.digitalinsights.supremeclients.com
SUMMARY:Biomarker discovery and disease pathology investigation using QIAGEN OmicSoft and Ingenuity Pathway Analysis
DESCRIPTION:In this training\, attendees will learn how to harness curated ‘omics datasets in OmicSoft DiseaseLand and curated research findings in IPA to discover new potential biomarkers. Using a neurological disorder as a case study\, we will:\n• Search public RNA-Seq datasets for tissue- and disease-specific differential expression in brain\n• Identify genes whose expression correlates with our factor within a sample group\n• Prioritize candidate biomarkers by disease vs. normal expression\n• Simulate biomarker activity changes to determine potential mechanisms of action\nInvestigation of inflammatory\, infectious\, oncological\, and other disorders can also be done using similar approach and will be highlighted during this training. \n  \nClick here to register.
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/biomarker-discovery-and-disease-pathology-investigation-using-qiagen-omicsoft-and-ingenuity-pathway-analysis-2/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Discovery,Webinar
END:VEVENT
END:VCALENDAR